CRISPRa identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2 – News-Medical.net

CRISPRa screening with real-world evidence identifies potential pharmaceutical targets for SARS-CoV2 CONTEXT:  New research from Stanford University School of Medicine in California has identified a potential viral entry mechanism through Continue Reading

Posted On :

NovaBiotics Announces Cysteamine Bitartrate (NM002) Included in REMAP-CAP Phase 3 Clinical Trial for Community Acquired Pneumonia – PRNewswire

CONTEXT:  Blurring the lines of real-world research and traditional Phase 3, NovaBiotics announce their intravenous cysteamine bitartrate therapy (NM002) has become part of the REMAP-CAP initiative.  REMAP-CAP is a global Continue Reading

Posted On :